1. What specific clinical and laboratory findings are essential in confirming the diagnosis of septic arthritis due to Staphylococcus aureus, and how do they differentiate it from other potential causes of joint pain and swelling?
2. Considering the diagnosis of septic arthritis, what are the possible complications associated with Staphylococcus aureus infections, and how should they be managed to prevent long-term joint damage?
3. How does the identification of methicillin-sensitive Staphylococcus aureus (MSSA) influence the choice of antibiotic therapy, and what additional information might be needed to ensure effective treatment?
4. In the context of Mrs. Thompson's diagnosis, what differential diagnoses should be considered, and what additional tests could help rule out other conditions?
5. Given the confirmed diagnosis of septic arthritis, what follow-up evaluations and monitoring strategies are crucial to assess treatment efficacy and prevent recurrence or complications?